65 related articles for article (PubMed ID: 38549930)
1. [Turcot syndrome].
Sunahara M; Nakagawara A
Nihon Rinsho; 2000 Jul; 58(7):1484-9. PubMed ID: 10921328
[TBL] [Abstract][Full Text] [Related]
2. Case report: Turcot syndrome type 2 in a developing country within the Caribbean.
Daniel-Abdool M; Griffith B; Bartels U; Bodkyn C; Dindial K
Front Oncol; 2024; 14():1331271. PubMed ID: 38549930
[TBL] [Abstract][Full Text] [Related]
3. Systemic considerations with pigmented fundus lesions and retinal pigment epithelium hamartomas in Turcot syndrome.
Mokhashi N; Cai LZ; Shields CL; Benson WE; Ho AC
Curr Opin Ophthalmol; 2021 Nov; 32(6):567-573. PubMed ID: 34456292
[TBL] [Abstract][Full Text] [Related]
4. Two girl patients with medulloblastoma. Case reports.
Marinău LD; Singer CE; Meşină C; Niculescu EC; Puiu I; Petrescu IO; Geormăneanu C; Enculescu AC; Tache DE; Purcaru ŞO; Răciulă S; Damian CL
Rom J Morphol Embryol; 2017; 58(3):1103-1108. PubMed ID: 29250697
[TBL] [Abstract][Full Text] [Related]
5. Bridging the Distance in the Caribbean: Telemedicine as a means to build capacity for care in paediatric cancer and blood disorders.
Adler E; Alexis C; Ali Z; Allen U; Bartels U; Bick C; Bird-Compton J; Bodkyn C; Boyle R; De Young S; Fleming-Carroll B; Gupta S; Ingram-Martin P; Irwin M; Kirby-Allen M; McLean-Salmon S; Mihelcic P; Richards-Dawson MA; Reece-Mills M; Shaikh F; Sinquee-Brown C; Thame M; Weitzman S; Wharfe G; Blanchette V
Stud Health Technol Inform; 2015; 209():1-8. PubMed ID: 25980698
[TBL] [Abstract][Full Text] [Related]
6. A novel APC gene mutation associated with a severe phenotype in a patient with Turcot syndrome.
Fritch Lilla SA; Yi JS; Hall BA; Moertel CL
J Pediatr Hematol Oncol; 2014 Apr; 36(3):e177-9. PubMed ID: 24309598
[TBL] [Abstract][Full Text] [Related]
7. Spectrum and prevalence of genetic predisposition in medulloblastoma: a retrospective genetic study and prospective validation in a clinical trial cohort.
Waszak SM; Northcott PA; Buchhalter I; Robinson GW; Sutter C; Groebner S; Grund KB; Brugières L; Jones DTW; Pajtler KW; Morrissy AS; Kool M; Sturm D; Chavez L; Ernst A; Brabetz S; Hain M; Zichner T; Segura-Wang M; Weischenfeldt J; Rausch T; Mardin BR; Zhou X; Baciu C; Lawerenz C; Chan JA; Varlet P; Guerrini-Rousseau L; Fults DW; Grajkowska W; Hauser P; Jabado N; Ra YS; Zitterbart K; Shringarpure SS; De La Vega FM; Bustamante CD; Ng HK; Perry A; MacDonald TJ; Hernáiz Driever P; Bendel AE; Bowers DC; McCowage G; Chintagumpala MM; Cohn R; Hassall T; Fleischhack G; Eggen T; Wesenberg F; Feychting M; Lannering B; Schüz J; Johansen C; Andersen TV; Röösli M; Kuehni CE; Grotzer M; Kjaerheim K; Monoranu CM; Archer TC; Duke E; Pomeroy SL; Shelagh R; Frank S; Sumerauer D; Scheurlen W; Ryzhova MV; Milde T; Kratz CP; Samuel D; Zhang J; Solomon DA; Marra M; Eils R; Bartram CR; von Hoff K; Rutkowski S; Ramaswamy V; Gilbertson RJ; Korshunov A; Taylor MD; Lichter P; Malkin D; Gajjar A; Korbel JO; Pfister SM
Lancet Oncol; 2018 Jun; 19(6):785-798. PubMed ID: 29753700
[TBL] [Abstract][Full Text] [Related]
8. Developing a partnership to improve health care delivery to children <18 years with cancer and blood disorders in the English-speaking Caribbean: lessons from the SickKids-Caribbean Initiative (SCI).
Reece-Mills M; Bodkyn C; Baxter JB; Allen U; Alexis C; Browne-Farmer C; Craig J; de Young S; Denburg A; Dindial K; Fleming-Carroll B; Gibson T; Gupta S; Knight-Madden J; Manley-Kucey M; Mclean-Salmon S; Ocho ON; Orrigio K; Read S; Sin Quee C; Smith B; Thame M; Wharfe G; Whitlock JA; Zlotkin S; Blanchette V
Lancet Reg Health Am; 2023 Oct; 26():100592. PubMed ID: 37727865
[TBL] [Abstract][Full Text] [Related]
9. Early-Onset Colorectal Cancer: Current Insights.
Ullah F; Pillai AB; Omar N; Dima D; Harichand S
Cancers (Basel); 2023 Jun; 15(12):. PubMed ID: 37370811
[TBL] [Abstract][Full Text] [Related]
10. A new era for optic pathway glioma: A developmental brain tumor with life-long health consequences.
Walker DA; Aquilina K; Spoudeas H; Pilotto C; Gan HW; Meijer L
Front Pediatr; 2023; 11():1038937. PubMed ID: 37033188
[TBL] [Abstract][Full Text] [Related]
11. Molecular Subgroup Is the Strongest Predictor of Medulloblastoma Outcome in a Resource-Limited Country.
Amayiri N; Swaidan M; Ibrahimi A; Hirmas N; Musharbash A; Bouffet E; Al-Hussaini M; Ramaswamy V
JCO Glob Oncol; 2021 Sep; 7():1442-1453. PubMed ID: 34609903
[TBL] [Abstract][Full Text] [Related]
12. Cancer predisposition in pediatric neuro-oncology-practical approaches and ethical considerations.
Hirsch S; Dikow N; Pfister SM; Pajtler KW
Neurooncol Pract; 2021 Oct; 8(5):526-538. PubMed ID: 34594567
[TBL] [Abstract][Full Text] [Related]
13. Childhood Cancer: Occurrence, Treatment and Risk of Second Primary Malignancies.
Zahnreich S; Schmidberger H
Cancers (Basel); 2021 May; 13(11):. PubMed ID: 34073340
[TBL] [Abstract][Full Text] [Related]
14. Cancer Predisposition Syndromes and Medulloblastoma in the Molecular Era.
Carta R; Del Baldo G; Miele E; Po A; Besharat ZM; Nazio F; Colafati GS; Piccirilli E; Agolini E; Rinelli M; Lodi M; Cacchione A; Carai A; Boccuto L; Ferretti E; Locatelli F; Mastronuzzi A
Front Oncol; 2020; 10():566822. PubMed ID: 33194646
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
